Mark T. Keating works in Electrophysiology affiliated with Novartis (Switzerland).
Mark T. Keating is a cardiologist and researcher known for his work on the genetic mechanisms of cardiovascular diseases. He currently serves as Chief Scientific Officer at City Therapeutics. He previously held positions at Harvard Medical School, Boston Children's Hospital, and Novartis, where he led cardiovascular research.
132 pubs · 44,094 cites · h-index 83
AB in Biology
Princeton University
1976
MD
Johns Hopkins University School of Medicine
1980
City Therapeutics
2023 - Present
Alnylam Pharmaceuticals
2018 - 2018
Novartis
2005 - 2016
Harvard Medical School and Boston Children's Hospital
2000 - 2005
University of Utah
1989 - 2000